BMY

Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036

04/13 04:47 am

Which Dividend Pharma Stock Should a Value Investor Choose Today?

04/12 08:28 pm

2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap

04/10 06:30 am

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

04/10 04:59 am

Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours

04/09 07:00 am

Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight

04/08 01:00 pm

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

04/06 01:20 pm

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

03/30 06:00 am

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

03/30 05:00 am

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

03/24 07:06 am

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

03/23 04:30 pm

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

03/20 01:57 pm

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

03/17 10:46 pm

The $3B Biotech With Two Shots On Goal

03/17 07:07 am

1 ETF That Could Turn $100 Per Month Into $67,380

03/15 05:05 am

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever

03/14 05:14 am

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

03/10 08:40 am

Abecma (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

03/10 05:46 am

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

03/09 07:00 am

2 Top Healthcare Dividend Stocks to Buy and Hold Forever

03/05 04:30 pm

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

03/05 05:44 am

OXB announces date for Capital Markets Day and participation in upcoming investor conferences

03/03 08:00 am

Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight

03/02 02:00 pm

Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement

03/01 12:30 am

A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

02/27 03:52 pm

One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

02/27 01:31 pm

Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients

02/26 03:26 pm

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors

02/24 09:00 am

Bristol-Myers Touts Promising Data From Blood Disorder Study

02/23 02:43 pm

Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma

02/19 09:00 am

CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

02/18 12:00 pm

Checkpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs

02/18 11:49 am

Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally

02/11 05:00 am

Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight

02/09 02:00 pm

Bristol Myers Flags Data-Rich 2026 After Solid Quarter

02/05 11:07 am

What's Going On With Bristol-Myers Squibb Stock Today?

02/04 02:40 pm

CytomX Therapeutics to Present at Upcoming February Conferences

02/04 09:00 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

01/27 02:43 pm

1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income

01/24 08:30 pm

Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/23 06:52 am

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

01/22 03:02 pm

The Best Stocks to Invest $1,000 in Right Now

01/21 12:45 pm

High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

01/21 12:00 pm

Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

01/21 10:43 am

U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

01/21 05:52 am

Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool

01/20 02:02 pm

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

01/14 04:30 am

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

01/13 02:00 pm